Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

Cipollini M, Landi S, Gemignani F.

Pharmgenomics Pers Med. 2014 Jul 23;7:173-91. doi: 10.2147/PGPM.S61693. eCollection 2014. Review.

2.

Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites.

Gong W, Xiao D, Ming G, Yin J, Zhou H, Liu Z.

J Diabetes. 2014 Jul;6(4):279-89. doi: 10.1111/1753-0407.12143. Epub 2014 Apr 15. Review.

PMID:
24606011
3.

MicroRNA binding site polymorphisms as biomarkers of cancer risk.

Pelletier C, Weidhaas JB.

Expert Rev Mol Diagn. 2010 Sep;10(6):817-29. doi: 10.1586/erm.10.59.

4.

Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding.

Pardini B, Rosa F, Barone E, Di Gaetano C, Slyskova J, Novotny J, Levy M, Garritano S, Vodickova L, Buchler T, Gemignani F, Landi S, Vodicka P, Naccarati A.

Clin Cancer Res. 2013 Nov 1;19(21):6044-56. doi: 10.1158/1078-0432.CCR-13-0314. Epub 2013 Sep 13.

5.

Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population.

Xu J, Yin Z, Gao W, Liu L, Yin Y, Liu P, Shu Y.

PLoS One. 2013 Oct 11;8(10):e77024. doi: 10.1371/journal.pone.0077024. eCollection 2013.

6.

MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs.

Liu C, Zhang F, Li T, Lu M, Wang L, Yue W, Zhang D.

BMC Genomics. 2012 Nov 23;13:661. doi: 10.1186/1471-2164-13-661.

7.

Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways.

Arnold M, Ellwanger DC, Hartsperger ML, Pfeufer A, Stümpflen V.

PLoS One. 2012;7(5):e36694. doi: 10.1371/journal.pone.0036694. Epub 2012 May 11.

8.

Polymorphism (rs16917496) at the miR-502 Binding Site of the Lysine Methyltransferase 5A (SET8) and Its Correlation with Colorectal Cancer in Iranians.

Mosallayi M, Simonian M, Khosravi S, Salehi AR, Khodadoostan M, Sebghatollahi V, Baradaran A, Salehi R.

Adv Biomed Res. 2017 Jul 14;6:77. doi: 10.4103/2277-9175.210656. eCollection 2017.

9.

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.

Cancer Res. 2010 Apr 1;70(7):2789-98. doi: 10.1158/0008-5472.CAN-09-3541. Epub 2010 Mar 23.

10.

Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.

Ye Q, Zhao X, Xu K, Li Q, Cheng J, Gao Y, Du J, Shi H, Zhou L.

Gene. 2013 Oct 10;528(2):132-8. doi: 10.1016/j.gene.2013.07.036. Epub 2013 Jul 31.

PMID:
23911300
11.

MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies.

Dzikiewicz-Krawczyk A.

Crit Rev Oncol Hematol. 2015 Jan;93(1):1-17. doi: 10.1016/j.critrevonc.2014.08.006. Epub 2014 Sep 2. Review.

PMID:
25217091
12.

Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.

Bagheri F, Mesrian Tanha H, Mojtabavi Naeini M, Ghaedi K, Azadeh M.

Mol Med Rep. 2016 May;13(5):4494-8. doi: 10.3892/mmr.2016.5078. Epub 2016 Mar 31.

PMID:
27035115
13.
14.

A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer.

Stegeman S, Moya L, Selth LA, Spurdle AB, Clements JA, Batra J.

Endocr Relat Cancer. 2015 Apr;22(2):265-76. doi: 10.1530/ERC-15-0013. Epub 2015 Feb 10.

PMID:
25670033
15.

Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs.

Anwar SL, Wulaningsih W, Watkins J.

Cancer Biol Med. 2017 Nov;14(4):387-395. doi: 10.20892/j.issn.2095-3941.2017.0050.

16.

A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.

Gao F, Xiong X, Pan W, Yang X, Zhou C, Yuan Q, Zhou L, Yang M.

PLoS One. 2015 Aug 14;10(8):e0135647. doi: 10.1371/journal.pone.0135647. eCollection 2015.

17.

Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis.

Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G, Sun J, Guo AY.

Hum Mutat. 2012 Jan;33(1):254-63. doi: 10.1002/humu.21641. Epub 2011 Nov 23.

PMID:
22045659
18.

Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets.

Gong Y, Wu CN, Xu J, Feng G, Xing QH, Fu W, Li C, He L, Zhao XZ.

Eur Neuropsychopharmacol. 2013 Oct;23(10):1182-9. doi: 10.1016/j.euroneuro.2012.12.002. Epub 2013 Jan 16.

PMID:
23332465
19.

A polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome.

Guo Z, Wu C, Wang X, Wang C, Zhang R, Shan B.

Int J Cancer. 2012 Sep 15;131(6):1318-22. doi: 10.1002/ijc.27352. Epub 2012 Jan 11.

20.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696

Supplemental Content

Support Center